SCHEMBL31185067

SCHEMBL31185067

CCOC(=O)C1(C)CCC(N2Cc3c(C)ccc(OC)c3NC2=O)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.36
▸ PDE4A P27815 3/20 0.35
▸ PDE4B Q07343 3/20 0.35
▸ PDE4C Q08493 3/20 0.35
▸ PDE4D Q08499 3/20 0.35
▸ MAPT P10636 1/20 0.35
▸ GAA P10253 2/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ HTR2C P28335 1/20 0.34
▸ HTR2B P41595 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ MAPK1 P28482 2/20 0.33
▸ USP2 O75604 2/20 0.33
▸ HTT P42858 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ LMNA P02545 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ ACHE P22303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31184987 0.88 HTR2B (0.36) MAPTHTR2AHTR2CHTR2BBRD4
SCHEMBL31184984 0.87 HTR2A (0.38) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL31184511 0.81 BRD4 (0.41) POLBMAPTGAAKMT2ASMN1; SMN2
SCHEMBL31184672 0.80 MAPT (0.36) MAPTKMT2AMAPK1SMN1; SMN2LMNA
SCHEMBL31184478 0.80 MAPT (0.38) POLBMAPTKMT2AMAPK1SMN1; SMN2
SCHEMBL31184793 0.78 ALDH1A1 (0.42) POLBMAPTKMT2ASMN1; SMN2LMNA
SCHEMBL31184867 0.77 ALDH1A1 (0.44) MAPTKMT2AMAPK1SMN1; SMN2KDM4E
SCHEMBL31184668 0.74 LMNA (0.42) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL31185060 0.72 SMN1; SMN2 (0.47) POLBMAPTMAPK1USP2HTT
SCHEMBL31184359 0.72 POLB (0.47) POLBMAPTMAPK1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024220626-A1 SMALL MOLECULE MODULATORS OF OGG1 AZKARRA THERAPEUTICS, INC. (US) 2024-10-24 — — WO disclosed
Send feedback